Lymphocytic choriomeningitis (LCM) virus-infected culture cells as targets were markedly reduced in numbers when incubated in vitro with spleen cells from LCM virus-immune mice, even if the cells were taken months after a subcutaneous immunizing infection of the donor animal. Spleen cells from mice persistently infected with LCM virus had no effect on target cells. Also, mitomycin C-blocked LCM virus-infected culture cells stimulated the incorporation of radiolabeled thymidine into spleen cells from LCM virus-immune mice.
No stimulation was observed with spleen cells from LCM virus carrier mice. It was concluded that cell-mediated immunity directed against LCM virion surface antigen(s) is absent in LCM virus carrier mice.
Neonatal or congenital contact of Mus musculus with the lymphocytic choriomeningitis (LCM) virus leads to a lifelong and inapparent infection (12) . Inability to eliminate the infectious virus was interpreted by Burnet and Fenner (1) to mean that the virus is accepted as self, and the persistent infection of mice with the LCM virus was regarded for many years as an example of virus-specific immunological tolerance. This concept was challenged by Oldstone and Dixon on the grounds that antibody, demonstrable by complement fixation test (20) , as well as virus-specific cellular immunity (21) , was detected in LCM virus carrier mice. In previous investigations of this laboratory, evidence was presented showing clearly that the "extractable complement-fixing activity" which is the antigen [s] corresponding to the antibody in carrier mice is not represented on the surface of either the virion or the infected cell (7, 13, 24 Elimination of macrophages. The spleen cell suspension was incubated at 37 C in the presence of carbonyl iron, and phagocytic cells were removed with the help of a powerful magnet (6) . To eliminate adhering cells, the spleen cell suspension was incubated for 30 min at 37 C in a column of glass wool, or the cells were incubated three times in succession for 1 h at 37 C in plastic petri dishes. After removal of phagocytic or adhering elements, respectively, the cells were washed twice, counted in the presence of erythrosin B, and adjusted to the desired concentration.
Incorporation by spleen cells of tritiated thymidine. Stimulator cells were CBA mouse fibroblasts (2 days after infection with LCM virus) treated in suspension with 100 tig of mitomycin C per ml for 30 min at 37 C and then washed four times with Hanks balanced salt solution. Spleen cells from LCM virus-immune CBA mice, 6 to 10 months after an immunizing infection, and from 7-to 9-month-old CBA carrier mice served as responders. Preliminary experiments had shown that a ratio of 40:1 was optimal for stimulation. Accordingly, 4 
RESULTS
Cytotoxic activity of spleen cells from LCM virus-immune mice. When spleen cells were taken from mice at intervals after a subcutaneous immunizing infection, cytotoxicity exceeding that exerted by normal spleen cells (see below) was first apparent 3 days after the immunizing infection. The peak of activity was attained around the tenth day, but even as long as 6 months after immunization of the donor mice, target cell numbers were markedly reduced. The results obtained with the syngeneic combination may be regarded as especially relevant (Table 1) . Many more data points were available from experiments where mouse spleen cells were cultivated with virus-infected Vero (monkey) cells as targets, and these data fully confirm the findings with CBA cells.
Cytotoxic reduction of noninfected culture cells by spleen cells from either immune or normal mice (in both the syngeneic and xenogeneic combinations) was never observed.
Effect of anti-theta antiserum or elimination of macrophages upon cytotoxicity of spleen cells from LCM virus-immune CBA mice. We attempted to find out whether the cytotoxic reduction of target cell numbers by spleen cells from immune mice required the presence of T cells. Adult CBA mice were immunized subcutaneously, and their spleen cells were treated with anti-theta antiserum and complement 45 days later. When these cells were employed in the cytotoxicity assay, effects upon CBA target cells were entirely absent. In contrast, the same number of erythrosin Bexcluding cells from the same spleen cell sus- [3H]thymidine uptake by spleen cells from carrier mice upon incubation with virus-in- upon contact with LCM virus-infected stimulator cells was measured, the stimulation index was found to vary around 1 (Table 2) , signifying absence of stimulation. Thus, this assay too failed to reveal virus-specific immunological reactivity of spleen cells from mice persistently infected with LCM virus.
DISCUSSION
Nonlethal infection of the adult mouse with the LCM virus induces solid immunity and virus elimination, as well as protection against reinfection, is mediated by immune cells rather than by antibody. This conclusion has been drawn previously (12) , and numerous reports from other laboratories attest to its general validity. When the 5'chromium release assay is utilized for demonstrating antiviral cellular immunity, maximal cytotoxic activity is found around the tenth day. Activity then drops rapidly and is low or even absent a few weeks after the immunizing infection of the donor mouse (3, 18) . In contrast, our procedure shows a peak at about the same time, but cytotoxic activity then remains high for months. One explanation for this difference may be the prolonged incubation period (2 days versus less than 20 possibly much more potent than the virus fully released from the cell. Alternatively, the possibility cannot be excluded that our mice had previous contact with cross-reacting antigen(s).
Cytotoxicity of spleen cells from immune mice for antigen-bearing target cells is a criterion for cell-mediated immunity. Immunity was confirmed by demonstrating the ability of LCM virus-infected culture cells to stimulate deoxyribonucleic acid (DNA) synthesis in immune cells. In contrast to the cytotoxicity assay, however, this method failed to show increased activity of spleen cells from normal mice as compared with cells from persistently infected mice; presumably, normal cells are not sufficiently stimulated to make differences apparent.
With spleen cells from LCM virus carrier mice, no immune response against virusinfected cells can be recognized in vitro, and this statement holds true whether the assessment of immunological activity is based on cytotoxic effects upon virus-infected target cells, or on increased DNA synthesis when cocultivated with mitomycin C-blocked, virusinfected stimulator cells. Consequently, as detected by these methods, mice persistently infected with LCM virus do not possess cellular immunity directed against virion surface antigens.
Using a cytotoxicity assay similar to the one used by us, Lundstedt (16) 10, 1974 antibody is sometimes detected. Of course, this does not imply that immunity is absent against all virus-induced antigens. In fact, this is unlikely a priori, and, when distinction is possible, immunity against nonvirion antigens such as tumor-specific transplantation antigens often seems to be present. Obviously, the present confusion in this field stems from the fact that the assays generally used test for numerous unspecified antigens, only some of which are represented on the virion surface. Returning to the LCM virus, we have some evidence, based on absorption experiments, that on the virusinfected cell only virion surface antigens are represented. Presumably, the immunizing antigen as well as the target for a cytotoxic contact is the budding virus which is present in large numbers on culture cells infected under conditions as applied here (17) . Hence, virion-specific immunological tolerance also includes the antigens on the cell surface.
